We are live on ! Find out more
MSL

Mackay Shields LLC Portfolio holdings

AUM $2.73B
1-Year Est. Return 2.13%
This Fund
S&P 500
This Quarter Est. Return
+0.7%
1 Year Est. Return
+2.13%
3 Year Est. Return
+7.81%
5 Year Est. Return
+19%
10 Year Est. Return
+113.23%
AUM
$10.6B
AUM Growth
-$29M
Cap. Flow
-$2.95B
Cap. Flow %
-27.83%
Top 10 Hldgs %
25.65%
Holding
722
New
10
Increased
39
Reduced
477
Closed
11

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$19.8M
2
TSM icon
TSMC
TSM
+$10.7M
3
MTCH icon
Match Group
MTCH
+$6.4M
4
VST icon
Vistra
VST
+$5.66M
5
CPLB
NYLI MacKay Core Plus Bond ETF
CPLB
+$4.99M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$36.4M
2
MSFT icon
Microsoft
MSFT
+$10.8M
3
AAPL icon
Apple
AAPL
+$10.4M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$6.41M
5
NEA icon
Nuveen AMT-Free Quality Municipal Income Fund
NEA
+$6.18M

Sector Composition

Rank Sector Weight
1 Technology 13.42%
2 Financials 7.36%
3 Healthcare 6.77%
4 Consumer Discretionary 6.29%
5 Communication Services 5.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
A icon
176
Agilent Technologies
A
$39.1B
$7.32M 0.07%
46,472
-1,343
-3% -$217K
FCX icon
177
Freeport-McMoran
FCX
$90B
$7.31M 0.07%
224,596
-6,484
-3% -$228K
EXC icon
178
Exelon
EXC
$48.6B
$7.22M 0.07%
209,323
-6,062
-3% -$207K
AIG icon
179
American International
AIG
$41.9B
$7.2M 0.07%
131,177
-3,797
-3% -$196K
ROP icon
180
Roper Technologies
ROP
$36.3B
$7.18M 0.07%
16,105
-466
-3% -$223K
VRTX icon
181
Vertex Pharmaceuticals
VRTX
$121B
$7.18M 0.07%
39,577
-1,146
-3% -$224K
EOG icon
182
EOG Resources
EOG
$78B
$7.16M 0.07%
89,248
-2,582
-3% -$188K
GPN icon
183
Global Payments
GPN
$22.1B
$7.1M 0.07%
45,036
-1,307
-3% -$227K
SNPS icon
184
Synopsys
SNPS
$71.5B
$7.01M 0.07%
23,420
-466
-2% -$141K
IQV icon
185
IQVIA
IQV
$34.7B
$7.01M 0.07%
29,248
-1,183
-4% -$299K
GD icon
186
General Dynamics
GD
$105B
$6.94M 0.07%
35,406
-584
-2% -$114K
EBAY icon
187
eBay
EBAY
$48.6B
$6.94M 0.07%
99,564
-4,098
-4% -$294K
PSA icon
188
Public Storage
PSA
$60.2B
$6.92M 0.07%
23,310
-675
-3% -$212K
MET icon
189
MetLife
MET
$61B
$6.89M 0.06%
111,567
-5,777
-5% -$348K
CARR icon
190
Carrier Global
CARR
$57.2B
$6.85M 0.06%
132,270
+3,878
+3% +$209K
KMB icon
191
Kimberly-Clark
KMB
$36.4B
$6.84M 0.06%
51,680
-1,494
-3% -$203K
TROW icon
192
T. Rowe Price
TROW
$25B
$6.82M 0.06%
34,670
-1,004
-3% -$211K
LHX icon
193
L3Harris
LHX
$55.9B
$6.77M 0.06%
30,745
-1,547
-5% -$352K
APH icon
194
Amphenol
APH
$188B
$6.7M 0.06%
183,102
-5,290
-3% -$194K
NEM icon
195
Newmont
NEM
$99.5B
$6.66M 0.06%
122,620
-3,545
-3% -$209K
MTCH icon
196
Match Group
MTCH
$8.84B
$6.6M 0.06%
+42,065
New +$6.4M
DOW icon
197
Dow Inc
DOW
$21.6B
$6.6M 0.06%
114,585
-3,306
-3% -$202K
SPG icon
198
Simon Property Group
SPG
$74.5B
$6.52M 0.06%
50,139
-1,454
-3% -$189K
BIIB icon
199
Biogen
BIIB
$29.9B
$6.49M 0.06%
22,938
-1,089
-5% -$357K
CDNS icon
200
Cadence Design Systems
CDNS
$90B
$6.45M 0.06%
42,590
-1,231
-3% -$188K
6 7
8
9 10

Similar funds

GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.73B AUM 28.24% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
CIAS
CBIZ Investment Advisory Services Independence, Ohio $2.74B AUM 14.19% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return

Mackay Shields LLC's Q3 2021 Portfolio in Review

As of Q3 2021, Mackay Shields LLC held 722 positions worth $10.6B, down 0.27% from $10.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Mackay Shields LLC withdrew a net $2.95B in Q3 2021, closing 11 positions and reducing 477 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $6.41M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Mackay Shields LLC opened a new position in Moderna worth $20.7M.

  • Mackay Shields LLC's largest Q3 2021 buy was Moderna: 53,663 shares worth $20.7M.
  • Mackay Shields LLC added most to TSMC in Q3 2021, an estimated $10.7M increase.
  • Mackay Shields LLC's biggest Q3 2021 reduction was Lam Research, cutting an estimated $36.4M.
  • Mackay Shields LLC fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $6.41M.
  • Mackay Shields LLC's ten largest holdings make up 26% of its $10.6B portfolio in Q3 2021.
  • Mackay Shields LLC opened 10 new positions and closed 11 in Q3 2021.
  • Mackay Shields LLC's portfolio value fell 0.27% quarter-over-quarter to $10.6B.

Based on Mackay Shields LLC's 13F filing for Q3 2021, filed 12 Nov 2021.